Sidney Farber

Sidney Farber was an American pathologist and oncologist whose groundbreaking work in the mid-20th century established the field of modern chemotherapy. Often called the "father of modern chemotherapy," his successful use of aminopterin to induce temporary remission in children with acute lymphoblastic leukemia in 1948 provided the first evidence that cancer could be treated with chemicals. His visionary leadership led to the founding of the Children's Cancer Research Foundation in 1947, which later evolved into the world-renowned Dana–Farber Cancer Institute in Boston.

Early life and education

He was born in Buffalo, New York, to Simon Farber and Matilda Farbstein, Jewish immigrants from Poland. After graduating from Lafayette High School, he earned his undergraduate degree from the University at Buffalo in 1923. He then attended Harvard Medical School, receiving his M.D. in 1927. His postgraduate training included an internship at Peter Bent Brigham Hospital and residencies in pathology at both Children's Hospital Boston and the Boston City Hospital, where he developed a deep interest in pediatric diseases.

Career and research

Farber began his career as a pathologist at Children's Hospital Boston and later became a professor at Harvard Medical School. His early research focused on the pathology of childhood diseases, but he became increasingly dedicated to understanding leukemia, then considered an invariably fatal condition. In 1947, he founded the Children's Cancer Research Foundation, an unprecedented institution dedicated solely to pediatric oncology research and care. His work attracted significant support from charities, including the Jimmy Fund, which became a major fundraising arm for his efforts.

Development of chemotherapy

Prior to Farber's work, the primary treatments for cancer were surgery and radiation therapy. Inspired by research on folic acid antagonists by Yellapragada Subbarow at Lederle Laboratories, Farber hypothesized these compounds could inhibit the rapid cell division seen in leukemia. In 1948, he administered aminopterin, a folic acid antagonist, to children with acute lymphoblastic leukemia and observed dramatic, though temporary, remissions. This landmark study, published in the New England Journal of Medicine, proved for the first time that drugs could induce remission in a malignant disease, launching the modern era of chemotherapy. His subsequent research pioneered combination drug therapies and the concept of adjuvant chemotherapy.

Legacy and honors

Farber's legacy is monumental in oncology. The Children's Cancer Research Foundation was renamed the Sidney Farber Cancer Center in 1973 and later became the Dana–Farber Cancer Institute, a world leader in cancer treatment and research affiliated with Harvard Medical School. His work directly influenced the establishment of the National Cancer Chemotherapy Service Center at the National Cancer Institute. Among his numerous honors are the Albert Lasker Award for Clinical Medical Research in 1966 and the American Cancer Society's Medal of Honor in 1972. The American Association for Cancer Research annually bestows the Sidney Farber Award for outstanding clinical research.

Personal life and death

He married Norman Wolcott in 1932, and they had four children. A dedicated physician and scientist, he was also a skilled pianist and an avid collector of modern art. Farber continued his work and advocacy until his death from a myocardial infarction in Boston on March 30, 1973. He is interred at the Temple Israel Cemetery in Wakefield, Massachusetts. His vision of a multidisciplinary approach to conquering cancer continues to guide the mission of the institute that bears his name. Category:American pathologists Category:American oncologists Category:Harvard Medical School alumni Category:1903 births Category:1973 deaths